K2 Therapeutics Names Ying Huang Chief Executive Officer

Company: K2 Therapeutics · Event Type: Leadership Change · Product/Asset: Ying Huang · Subject: Leadership · Event Date: August 11, 2026 Summary K2 Therapeutics appointed Ying Huang, Ph.D., as chief executive officer. Huang previously served as chief executive officer and a director of Legend Biotech,…